カテゴリ： GlobalInfoResearch, 世界, 部品/材料

緊急止血用止血剤&ガーゼのグローバル市場2023：ゼオライト、キトサン、フィブリン、その他

■ 英語タイトル：Global Hemostatic Agents and Gauze for Emergency Bleeding Control Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG1144）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG1144
■ 発行日：2023年8月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[緊急止血用止血剤&ガーゼのグローバル市場2023：ゼオライト、キトサン、フィブリン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、緊急止血用止血剤&ガーゼのグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の緊急止血用止血剤&ガーゼ市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 緊急止血用止血剤&ガーゼの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

緊急止血用止血剤&ガーゼ市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・ゼオライト、キトサン、フィブリン、その他

用途別セグメント
・応急処置、アウトドアスポーツ、法執行機関、軍事、その他

主要な市場プレーヤー
・Teleflex、Medtrade Products、LifeScience PLUS、RevMedx、Innovative Trauma Care、Hangzhou Zeochuang Life Science and Technology

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、緊急止血用止血剤&ガーゼ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な緊急止血用止血剤&ガーゼメーカーの企業概要、2019年～2022年までの緊急止血用止血剤&ガーゼの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な緊急止血用止血剤&ガーゼメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別緊急止血用止血剤&ガーゼの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの緊急止血用止血剤&ガーゼの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での緊急止血用止血剤&ガーゼ市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および緊急止血用止血剤&ガーゼの産業チェーンを掲載しています。
・第14、15章では、緊急止血用止血剤&ガーゼの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 緊急止血用止血剤&ガーゼの概要
– 種類別分析（2018年vs2022年vs2029年）：ゼオライト、キトサン、フィブリン、その他
– 用途別分析（2018年vs2022年vs2029年）：応急処置、アウトドアスポーツ、法執行機関、軍事、その他
– 世界の緊急止血用止血剤&ガーゼ市場規模・予測
– 世界の緊急止血用止血剤&ガーゼ生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Teleflex、Medtrade Products、LifeScience PLUS、RevMedx、Innovative Trauma Care、Hangzhou Zeochuang Life Science and Technology
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ゼオライト、キトサン、フィブリン、その他
・用途別分析2018年-2029年：応急処置、アウトドアスポーツ、法執行機関、軍事、その他
・緊急止血用止血剤&ガーゼの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・緊急止血用止血剤&ガーゼのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・緊急止血用止血剤&ガーゼのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・緊急止血用止血剤&ガーゼの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・緊急止血用止血剤&ガーゼの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Hemostatic Agents and Gauze for Emergency Bleeding Control
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Zeolite
1.3.3 Chitosan
1.3.4 Fibrin
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 First Aid
1.4.3 Outdoor Sports
1.4.4 Law Enforcement
1.4.5 Military
1.4.6 Other
1.5 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Market Size & Forecast
1.5.1 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity (2018-2029)
1.5.3 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Teleflex
2.1.1 Teleflex Details
2.1.2 Teleflex Major Business
2.1.3 Teleflex Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
2.1.4 Teleflex Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teleflex Recent Developments/Updates
2.2 Medtrade Products
2.2.1 Medtrade Products Details
2.2.2 Medtrade Products Major Business
2.2.3 Medtrade Products Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
2.2.4 Medtrade Products Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Medtrade Products Recent Developments/Updates
2.3 LifeScience PLUS
2.3.1 LifeScience PLUS Details
2.3.2 LifeScience PLUS Major Business
2.3.3 LifeScience PLUS Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
2.3.4 LifeScience PLUS Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 LifeScience PLUS Recent Developments/Updates
2.4 RevMedx
2.4.1 RevMedx Details
2.4.2 RevMedx Major Business
2.4.3 RevMedx Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
2.4.4 RevMedx Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 RevMedx Recent Developments/Updates
2.5 Innovative Trauma Care
2.5.1 Innovative Trauma Care Details
2.5.2 Innovative Trauma Care Major Business
2.5.3 Innovative Trauma Care Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
2.5.4 Innovative Trauma Care Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Innovative Trauma Care Recent Developments/Updates
2.6 Hangzhou Zeochuang Life Science and Technology
2.6.1 Hangzhou Zeochuang Life Science and Technology Details
2.6.2 Hangzhou Zeochuang Life Science and Technology Major Business
2.6.3 Hangzhou Zeochuang Life Science and Technology Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
2.6.4 Hangzhou Zeochuang Life Science and Technology Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hangzhou Zeochuang Life Science and Technology Recent Developments/Updates
3 Competitive Environment: Hemostatic Agents and Gauze for Emergency Bleeding Control by Manufacturer
3.1 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Revenue by Manufacturer (2018-2023)
3.3 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hemostatic Agents and Gauze for Emergency Bleeding Control by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hemostatic Agents and Gauze for Emergency Bleeding Control Manufacturer Market Share in 2022
3.4.2 Top 6 Hemostatic Agents and Gauze for Emergency Bleeding Control Manufacturer Market Share in 2022
3.5 Hemostatic Agents and Gauze for Emergency Bleeding Control Market: Overall Company Footprint Analysis
3.5.1 Hemostatic Agents and Gauze for Emergency Bleeding Control Market: Region Footprint
3.5.2 Hemostatic Agents and Gauze for Emergency Bleeding Control Market: Company Product Type Footprint
3.5.3 Hemostatic Agents and Gauze for Emergency Bleeding Control Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Market Size by Region
4.1.1 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Region (2018-2029)
4.1.2 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Region (2018-2029)
4.1.3 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Region (2018-2029)
4.2 North America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029)
4.3 Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029)
4.4 Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029)
4.5 South America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029)
4.6 Middle East and Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2029)
5.2 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Type (2018-2029)
5.3 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2029)
6.2 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Application (2018-2029)
6.3 Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Application (2018-2029)
7 North America
7.1 North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2029)
7.2 North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2029)
7.3 North America Hemostatic Agents and Gauze for Emergency Bleeding Control Market Size by Country
7.3.1 North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2018-2029)
7.3.2 North America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2029)
8.2 Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2029)
8.3 Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Market Size by Country
8.3.1 Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2018-2029)
8.3.2 Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Market Size by Region
9.3.1 Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2029)
10.2 South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2029)
10.3 South America Hemostatic Agents and Gauze for Emergency Bleeding Control Market Size by Country
10.3.1 South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2018-2029)
10.3.2 South America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Market Size by Country
11.3.1 Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Hemostatic Agents and Gauze for Emergency Bleeding Control Market Drivers
12.2 Hemostatic Agents and Gauze for Emergency Bleeding Control Market Restraints
12.3 Hemostatic Agents and Gauze for Emergency Bleeding Control Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Hemostatic Agents and Gauze for Emergency Bleeding Control and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hemostatic Agents and Gauze for Emergency Bleeding Control
13.3 Hemostatic Agents and Gauze for Emergency Bleeding Control Production Process
13.4 Hemostatic Agents and Gauze for Emergency Bleeding Control Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hemostatic Agents and Gauze for Emergency Bleeding Control Typical Distributors
14.3 Hemostatic Agents and Gauze for Emergency Bleeding Control Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Teleflex Basic Information, Manufacturing Base and Competitors
Table 4. Teleflex Major Business
Table 5. Teleflex Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
Table 6. Teleflex Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Teleflex Recent Developments/Updates
Table 8. Medtrade Products Basic Information, Manufacturing Base and Competitors
Table 9. Medtrade Products Major Business
Table 10. Medtrade Products Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
Table 11. Medtrade Products Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Medtrade Products Recent Developments/Updates
Table 13. LifeScience PLUS Basic Information, Manufacturing Base and Competitors
Table 14. LifeScience PLUS Major Business
Table 15. LifeScience PLUS Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
Table 16. LifeScience PLUS Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. LifeScience PLUS Recent Developments/Updates
Table 18. RevMedx Basic Information, Manufacturing Base and Competitors
Table 19. RevMedx Major Business
Table 20. RevMedx Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
Table 21. RevMedx Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. RevMedx Recent Developments/Updates
Table 23. Innovative Trauma Care Basic Information, Manufacturing Base and Competitors
Table 24. Innovative Trauma Care Major Business
Table 25. Innovative Trauma Care Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
Table 26. Innovative Trauma Care Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Innovative Trauma Care Recent Developments/Updates
Table 28. Hangzhou Zeochuang Life Science and Technology Basic Information, Manufacturing Base and Competitors
Table 29. Hangzhou Zeochuang Life Science and Technology Major Business
Table 30. Hangzhou Zeochuang Life Science and Technology Hemostatic Agents and Gauze for Emergency Bleeding Control Product and Services
Table 31. Hangzhou Zeochuang Life Science and Technology Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hangzhou Zeochuang Life Science and Technology Recent Developments/Updates
Table 33. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 34. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 36. Market Position of Manufacturers in Hemostatic Agents and Gauze for Emergency Bleeding Control, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Hemostatic Agents and Gauze for Emergency Bleeding Control Production Site of Key Manufacturer
Table 38. Hemostatic Agents and Gauze for Emergency Bleeding Control Market: Company Product Type Footprint
Table 39. Hemostatic Agents and Gauze for Emergency Bleeding Control Market: Company Product Application Footprint
Table 40. Hemostatic Agents and Gauze for Emergency Bleeding Control New Market Entrants and Barriers to Market Entry
Table 41. Hemostatic Agents and Gauze for Emergency Bleeding Control Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Region (2018-2023) & (Tons)
Table 43. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Region (2024-2029) & (Tons)
Table 44. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Region (2018-2023) & (US$/Ton)
Table 47. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Region (2024-2029) & (US$/Ton)
Table 48. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2023) & (Tons)
Table 49. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2024-2029) & (Tons)
Table 50. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Type (2018-2023) & (US$/Ton)
Table 53. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Type (2024-2029) & (US$/Ton)
Table 54. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2023) & (Tons)
Table 55. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2024-2029) & (Tons)
Table 56. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Application (2018-2023) & (US$/Ton)
Table 59. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Application (2024-2029) & (US$/Ton)
Table 60. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2023) & (Tons)
Table 61. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2024-2029) & (Tons)
Table 62. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2023) & (Tons)
Table 63. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2024-2029) & (Tons)
Table 64. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2018-2023) & (Tons)
Table 65. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2024-2029) & (Tons)
Table 66. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2023) & (Tons)
Table 69. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2024-2029) & (Tons)
Table 70. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2023) & (Tons)
Table 71. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2024-2029) & (Tons)
Table 72. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2018-2023) & (Tons)
Table 73. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2024-2029) & (Tons)
Table 74. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2023) & (Tons)
Table 77. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2024-2029) & (Tons)
Table 78. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2023) & (Tons)
Table 79. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2024-2029) & (Tons)
Table 80. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Region (2018-2023) & (Tons)
Table 81. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Region (2024-2029) & (Tons)
Table 82. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2023) & (Tons)
Table 85. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2024-2029) & (Tons)
Table 86. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2023) & (Tons)
Table 87. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2024-2029) & (Tons)
Table 88. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2018-2023) & (Tons)
Table 89. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Country (2024-2029) & (Tons)
Table 90. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2018-2023) & (Tons)
Table 93. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Type (2024-2029) & (Tons)
Table 94. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2018-2023) & (Tons)
Table 95. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Application (2024-2029) & (Tons)
Table 96. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Region (2018-2023) & (Tons)
Table 97. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity by Region (2024-2029) & (Tons)
Table 98. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Hemostatic Agents and Gauze for Emergency Bleeding Control Raw Material
Table 101. Key Manufacturers of Hemostatic Agents and Gauze for Emergency Bleeding Control Raw Materials
Table 102. Hemostatic Agents and Gauze for Emergency Bleeding Control Typical Distributors
Table 103. Hemostatic Agents and Gauze for Emergency Bleeding Control Typical Customers
List of Figures
Figure 1. Hemostatic Agents and Gauze for Emergency Bleeding Control Picture
Figure 2. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Type in 2022
Figure 4. Zeolite Examples
Figure 5. Chitosan Examples
Figure 6. Fibrin Examples
Figure 7. Other Examples
Figure 8. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Application in 2022
Figure 10. First Aid Examples
Figure 11. Outdoor Sports Examples
Figure 12. Law Enforcement Examples
Figure 13. Military Examples
Figure 14. Other Examples
Figure 15. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity (2018-2029) & (Tons)
Figure 18. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price (2018-2029) & (US$/Ton)
Figure 19. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Hemostatic Agents and Gauze for Emergency Bleeding Control by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Hemostatic Agents and Gauze for Emergency Bleeding Control Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Hemostatic Agents and Gauze for Emergency Bleeding Control Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Type (2018-2029) & (US$/Ton)
Figure 34. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Hemostatic Agents and Gauze for Emergency Bleeding Control Average Price by Application (2018-2029) & (US$/Ton)
Figure 37. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Region (2018-2029)
Figure 57. China Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Hemostatic Agents and Gauze for Emergency Bleeding Control Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Hemostatic Agents and Gauze for Emergency Bleeding Control Market Drivers
Figure 78. Hemostatic Agents and Gauze for Emergency Bleeding Control Market Restraints
Figure 79. Hemostatic Agents and Gauze for Emergency Bleeding Control Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Hemostatic Agents and Gauze for Emergency Bleeding Control in 2022
Figure 82. Manufacturing Process Analysis of Hemostatic Agents and Gauze for Emergency Bleeding Control
Figure 83. Hemostatic Agents and Gauze for Emergency Bleeding Control Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source

※参考情報

緊急止血用止血剤とガーゼは、出血が発生した際の迅速な対応を目的とした重要な医療資材です。これらは特に外傷や手術中の出血を制御するために使用され、救命のための第一歩として多くの場面で活躍しています。以下に、これらの概念について詳細に説明します。

止血剤の定義は、出血を迅速に止めるための薬剤や物質を指します。これには化学的な止血剤、天然由来の物質、または生体材料を用いた製品が含まれます。止血剤は、血液の凝固を促進する作用を持ち、出血の程度や部位に応じて選択されます。一方、止血ガーゼは、物理的に出血を圧迫して止めたり、止血剤と一体化した製品もあったりします。これにより、出血の制御を助ける役割を果たします。

まず、止血剤の特徴について考えます。緊急止血剤は、迅速に作用することが求められます。出血が起こってから短時間で使用しなければならないため、すぐに効果を発揮できる成分が重要です。また、止血剤は使用後に体内で不快な反応を引き起こさないことも求められます。生体適合性が高く、安全性が保証されていることが前提です。さらに、抗感染効果や創傷治癒促進効果を持つ製品も開発されており、多機能な製品が増えています。

次に、止血剤の種類について説明します。止血剤は大きく分けて、化学合成によるもの、天然由来のもの、生体材料を用いたものがあります。具体的には、一般的な合成止血剤としてはフィブリノゲンやトロンビンを含む製品があり、これらは血液の凝固を促進する働きを持ちます。天然由来の止血剤としては、海藻から抽出されたアルギン酸塩やゼラチン、コラーゲンが挙げられます。これらは自然由来の成分で、身体に優しく、止血効果を持つ特性があります。また、生体材料を用いた製品では、特に多孔質なスコフォードや繊維質な製品が開発されており、出血部位に接触することで物理的および化学的に止血を促進します。

出血制御における止血剤の用途は多岐にわたります。外傷や事故による急性出血、手術中の予防的止血、または慢性的な病状による出血の管理など、さまざまな状況で活用されます。特に外科手術では、手術開始前、手術中、そして手術後の出血管理が重要です。さらに、緊急医療現場や救急隊において、迅速に出血を制御することが救命につながるため、必需品となっています。

止血ガーゼも止血剤と同様に重要な役割を果たします。通常のガーゼに比べ、止血ガーゼは出血を迅速にコントロールするための特別な処理が施されています。たとえば、ガーゼ自体に止血剤を含むものや、圧迫止血を実現するために設計された特殊な形状の製品が挙げられます。止血ガーゼは、基本的には出血部位に直接貼り付けて圧迫し、血液の流出を防ぎます。圧迫止血は血管収縮を促し、出血の拡大を防ぐためにも非常に効果的です。

関連技術も止血剤や止血ガーゼの進化に寄与しています。最近の研究や開発により、より高度な止血技術が導入されています。たとえば、ナノテクノロジーを利用した止血剤の開発が進行中です。これにより、細かい構造を持つ止血剤が作られ、出血部位に迅速に吸着・効果を発揮することが期待されています。また、生体材料を用いた生体適合性の高い製品も研究されており、将来的にはより安全で効果的な止血剤が普及する可能性があります。

このように、緊急止血用止血剤およびガーゼは、出血の制御において欠かせない重要な資材です。これらは、特に緊急時において迅速な対応が求められる場面で、その効果を発揮します。外傷や手術、または医療現場での利用が一般的ですが、今後の技術革新によってますます多様化し、より効果的な製品が登場することが期待されています。出血制御の重要性を再認識し、これらの資材を適切に使用することが、無駄な命を救うために極めて大切です。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 緊急止血用止血剤&ガーゼの世界市場2023-2029：ゼオライト、キトサン、フィブリン、その他
  • エレクトロスピニングキトサンナノファイバーの世界市場2023-2029：キトサン/ポリエチレンオキサイド（PEO）ナノファイバー、 キトサン/銀ナノファイバー、 キトサン/ヒドロキシアパタイト（HA）ナノファイバー、 キトサン/セルロースナノファイバー、 キトサン/ポリカプロラクトン（PCL）ナノファイバー、 その他
  • キトサンスポンジの世界市場2023-2029：架橋キトサンスポンジ、キトサン・コラーゲンスポンジ、銀担持キトサンスポンジ、キトサン・ゼラチンスポンジ、キトサン・ヒアルロン酸スポンジ
  • 止血ジェルの世界市場2025-2031：フィブリン、ゼラチン、その他
  • 外科用シーラントのグローバル市場2023：コラーゲン、フィブリン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG1144 )"緊急止血用止血剤&ガーゼのグローバル市場2023：ゼオライト、キトサン、フィブリン、その他" (英文：Global Hemostatic Agents and Gauze for Emergency Bleeding Control Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。